Influence of cardiogenic shock with or without the use of intra-aortic balloon pump on mortality in patients with ST-segment elevation myocardial infarction

Goldberg, 1999, Temporal trends in cardiogenic shock complicating acute myocardial infarction, N Engl J Med, 340, 1162, 10.1056/NEJM199904153401504 Hochman, 1999, Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock, N Engl J Med, 341, 625, 10.1056/NEJM199908263410901 Jeger, 2008, Ten-year trends in the incidence and treatment of cardiogenic shock, Ann Intern Med, 149, 618, 10.7326/0003-4819-149-9-200811040-00005 Thiele, 2010, Shock in acute myocardial infarction: the Cape Horn for trials?, Eur Heart J, 31, 1828, 10.1093/eurheartj/ehq220 Steg, 2012, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 Bahekar, 2012, Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis, J Cardiovasc Pharmacol Ther, 17, 44, 10.1177/1074248410395019 Prondzinsky, 2010, Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome, Crit Care Med, 38, 152, 10.1097/CCM.0b013e3181b78671 Thiele, 2012, Intraaortic balloon support for myocardial infarction with cardiogenic shock, N Engl J Med, 367, 1287, 10.1056/NEJMoa1208410 Lindholm, 2003, Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development, Eur Heart J, 24, 258, 10.1016/S0195-668X(02)00429-3 Jensen, 2007, Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions, J Am Coll Cardiol, 50, 463, 10.1016/j.jacc.2007.06.002 Andersen, 2003, A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction, N Engl J Med, 349, 733, 10.1056/NEJMoa025142 Pedersen, 2006, The Danish Civil Registration System. A cohort of eight million persons, Dan Med Bull, 53, 441 Frank, 2000, Epidemiology. When an entire country is a cohort, Science, 287, 2398, 10.1126/science.287.5462.2398 Barron, 2001, The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2, Am Heart J, 141, 933, 10.1067/mhj.2001.115295 Holmes, 1995, Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries, J Am Coll Cardiol, 26, 668, 10.1016/0735-1097(95)00215-P Zeymer, 2011, Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI, EuroIntervention, 7, 437, 10.4244/EIJV7I4A72 Schiele, 2010, Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction, Eur Heart J, 31, 2614, 10.1093/eurheartj/ehq305 Jensen, 2012, Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction, Am J Cardiol, 109, 629, 10.1016/j.amjcard.2011.10.018